RUNX3 and neoplasm: RUNX3 is generally considered as a TSG in human neoplasia as a multitude of epithelial cancers exhibit inactivation of RUNX3 [18], including ovarian carcinoma [19], although oncogenic function of RUNX3 in EOC was also suggested [20].